Clinical Trials for Mesothelioma Patients: Vandetanib Inclusion and Exclusion Criteria

Read about the inclusion and exclusion criteria for a current clinical trial being conducted to study the effects of Vandetanib on patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, this study is only being conducted in Germany and Switzerland.

Inclusion Criteria:
Diagnosed with mesothelioma
Previously treated with only one course of chemotherapy for mesothelioma
No previous treatment with vinorelbine
No serious heart problems within the last 3 months

Exclusion Criteria:
Serious abnormal laboratory values
Severe or uncontrolled disease or condition as judged by the Investigator
Pregnant or breast-feeding women
Other cancers within the last 5 years
Major surgery or radiation therapy within 4 weeks prior to starting study therapy
Receipt of any investigational agents within 30 days prior to commencing study treatment.

If you or a loved one has been diagnosed with an Asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading Asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.